These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
248 related articles for article (PubMed ID: 34573100)
21. Protein Misfolding and ER Stress in Huntington's Disease. Shacham T; Sharma N; Lederkremer GZ Front Mol Biosci; 2019; 6():20. PubMed ID: 31001537 [TBL] [Abstract][Full Text] [Related]
22. Altered Aconitase 2 Activity in Huntington's Disease Peripheral Blood Cells and Mouse Model Striatum. Chen CM; Wu YR; Chang KH Int J Mol Sci; 2017 Nov; 18(11):. PubMed ID: 29160844 [TBL] [Abstract][Full Text] [Related]
23. The neuroprotective transcription factor ATF5 is decreased and sequestered into polyglutamine inclusions in Huntington's disease. Hernández IH; Torres-Peraza J; Santos-Galindo M; Ramos-Morón E; Fernández-Fernández MR; Pérez-Álvarez MJ; Miranda-Vizuete A; Lucas JJ Acta Neuropathol; 2017 Dec; 134(6):839-850. PubMed ID: 28861715 [TBL] [Abstract][Full Text] [Related]
24. Mutant huntingtin impairs the post-Golgi trafficking of brain-derived neurotrophic factor but not its Val66Met polymorphism. del Toro D; Canals JM; Ginés S; Kojima M; Egea G; Alberch J J Neurosci; 2006 Dec; 26(49):12748-57. PubMed ID: 17151278 [TBL] [Abstract][Full Text] [Related]
25. PRMT5- mediated symmetric arginine dimethylation is attenuated by mutant huntingtin and is impaired in Huntington's disease (HD). Ratovitski T; Arbez N; Stewart JC; Chighladze E; Ross CA Cell Cycle; 2015; 14(11):1716-29. PubMed ID: 25927346 [TBL] [Abstract][Full Text] [Related]
26. Does tissue transglutaminase play a role in Huntington's disease? Lesort M; Chun W; Tucholski J; Johnson GV Neurochem Int; 2002 Jan; 40(1):37-52. PubMed ID: 11738471 [TBL] [Abstract][Full Text] [Related]
27. Challenges of Huntington's disease and quest for therapeutic biomarkers. Kotrcova E; Jarkovska K; Valekova I; Zizkova M; Motlik J; Gadher SJ; Kovarova H Proteomics Clin Appl; 2015 Feb; 9(1-2):147-58. PubMed ID: 25290828 [TBL] [Abstract][Full Text] [Related]
28. Exploring the role of high-mobility group box 1 (HMGB1) protein in the pathogenesis of Huntington's disease. Angelopoulou E; Paudel YN; Piperi C J Mol Med (Berl); 2020 Mar; 98(3):325-334. PubMed ID: 32036391 [TBL] [Abstract][Full Text] [Related]
29. Huntington's Disease and Mitochondria. Jodeiri Farshbaf M; Ghaedi K Neurotox Res; 2017 Oct; 32(3):518-529. PubMed ID: 28639241 [TBL] [Abstract][Full Text] [Related]
30. AMPK-α1 functions downstream of oxidative stress to mediate neuronal atrophy in Huntington's disease. Ju TC; Chen HM; Chen YC; Chang CP; Chang C; Chern Y Biochim Biophys Acta; 2014 Sep; 1842(9):1668-80. PubMed ID: 24946181 [TBL] [Abstract][Full Text] [Related]
34. Cystamine increases L-cysteine levels in Huntington's disease transgenic mouse brain and in a PC12 model of polyglutamine aggregation. Fox JH; Barber DS; Singh B; Zucker B; Swindell MK; Norflus F; Buzescu R; Chopra R; Ferrante RJ; Kazantsev A; Hersch SM J Neurochem; 2004 Oct; 91(2):413-22. PubMed ID: 15447674 [TBL] [Abstract][Full Text] [Related]
35. Targeting the UPR transcription factor XBP1 protects against Huntington's disease through the regulation of FoxO1 and autophagy. Vidal RL; Figueroa A; Court FA; Thielen P; Molina C; Wirth C; Caballero B; Kiffin R; Segura-Aguilar J; Cuervo AM; Glimcher LH; Hetz C Hum Mol Genet; 2012 May; 21(10):2245-62. PubMed ID: 22337954 [TBL] [Abstract][Full Text] [Related]
36. Reduced Expression of Foxp1 as a Contributing Factor in Huntington's Disease. Louis Sam Titus ASC; Yusuff T; Cassar M; Thomas E; Kretzschmar D; D'Mello SR J Neurosci; 2017 Jul; 37(27):6575-6587. PubMed ID: 28550168 [TBL] [Abstract][Full Text] [Related]